Lupus Vasculitis, Central Nervous System: Clinical Trials

1 trial for Lupus Vasculitis, Central Nervous System, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Lupus Vasculitis, Central Nervous System: new trials by email Literature Review of Lupus Vasculitis, Central Nervous System trials Research Report on Lupus Vasculitis, Central Nervous System

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
EG-501 for Cognitive Impairment in Neuropsychiatric SLE (NPSLE): Efficacy and Safety Study
Placebo, EG-501 - Neuropsychiatric Systemic Lupus Erythematosus, Systemic Lupus Erythematosus (SLE)
Phase 2CompletedEvergreen Therapeutics, Inc.1312018-08-232025-12-15

Narrower conditions

Cognitive Dysfunction (1)  ·  Lupus Erythematosus, Systemic (1)

Broader conditions

Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Brain Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Central Nervous System Infections (1)  ·  Central Nervous System Viral Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Cognition Disorders (1)  ·  Connective Tissue Diseases (1)  ·  Encephalitis (1)  ·  Immune System Diseases (1)  ·  Infections (1)  ·  Meningitis (1)  ·  Meningoencephalitis (1)

Sponsors

Evergreen Therapeutics, Inc. (1)

Countries

United States (1)

Top investigators

Leslie J. Crofford, M.D. (1)